Medicare beneficiaries have the clearest alternative through the GLP-1 Bridge
Very few patients require the maximum dose
Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes
On the other hand, while the triagonist, GLP1/GIP/Glucagon, was very effective in terms of body weight lowering, in keeping with previous references 42 , treatment of PWA mice led to a massive, likely detrimental weight loss, also at the expense of lean mass, that was not bound to clear amelioration of glucose intolerance in androgenized female mice
Severe reactions are rare, but as with any treatment, its essential to consult a healthcare provider to discuss any concerns
Both blends are covered in the GLOW vs KLOW comparison